Distinct MAP kinase pathways in yeast share several signaling components [1, 2] , including the PAK Ste20 and the MAPKKK Ste11, yet signaling is specific. Mating pheromones trigger an initial step in which Ste20 activates Ste11 [3] , and this requires plasma membrane recruitment of the MAP kinase cascade scaffold protein, Ste5 [4] [5] [6] [7] . Here, we demonstrate an additional role for Ste5 membrane localization. Once Ste11 is activated, signaling through the mating pathway remains minimal but is substantially amplified when Ste5 is recruited to the membrane either by the Gbg dimer or by direct membrane targeting, even to internal membranes. Ste11 signaling is also amplified by Ste5 oligomerization and by a hyperactivating mutation in the Ste7 binding region of Ste5. We suggest a model in which membrane recruitment of Ste5 concentrates its binding partners and thereby amplifies signaling through the kinase cascade. We find similar behavior in the osmotically responsive HOG pathway. Remarkably, while both pheromone and hyperosmotic stimuli amplify signaling from constitutively active Ste11, the resulting signaling output remains pathway specific. These findings suggest a common mode of regulation in which pathway stimuli both initiate and amplify MAP kinase cascade signaling. The regulation of rate-limiting steps that lie after a branchpoint from shared components helps ensure signaling specificity.
In two yeast MAP kinase cascades, the mating and HOG pathways ( Figure 1A ), membrane recruitment of a scaffold protein [4, 8] promotes an initial Ste20 / Ste11 activation step [3] . Other functional consequences of membrane recruitment are unexplored, but conceivably could include enhancement of signaling efficiency or fidelity. Theoretically, the sharing of signaling intermediates among multiple pathways ( Figure 1A ) could be relatively benign if rate-limiting steps that lie after the branchpoint were regulated by specific pathway stimuli ( Figure 1B ). To evaluate which steps in the mating pathway are rate limiting, we used hyperactive mutants ( Figure 1C ). Constitutively active forms of Cdc42 (CDC42 L61 ; [9] ) and Ste20 (STE20DN; [10] ) were overexpressed (P GAL1 ), and an activated form of Ste11 (STE11-4; [3, 11] ) was expressed from its native promoter. Each mutant alone caused minimal signaling compared to simultaneous treatment with pheromone (a-factor; Figure 1C ), consistent with previous findings with STE11-4 [12] [13] [14] . For clarity, in the remainder of this study we refer to this stimulated increase in signaling beyond that provided by constitutively active pathway components as ''amplification.' ' While these results suggest regulatable, rate-limiting steps downstream of Ste11, a caveat of the Ste11-4 mutant is that it may be only partially activated and thus still regulatable via phosphorylation sites in the Ste11 N terminus [3] . Indeed, signaling by Ste11-4 was strongly reduced when these sites were replaced with alanine residues (Ste11-4/Ala3; Figure 1E ). To eliminate regulatory input via these phosphorylation sites, we used the Ste11-Asp3 mutant, which contains aspartate replacements ( Figure 1D ) and signals constitutively upon overexpression [3] . When expressed from its native promoter, the Ste11-Asp3 mutant, like Ste11-4, gave only mild basal signaling that was still amplified dramatically by pheromone ( Figure 1E , left), as did a combined mutant harboring activating mutations in both regions (Ste11-4/Asp3). Nevertheless, each activated mutant allowed a robust response to pheromone in ste11D ste20D cells ( Figure 1E , center). Therefore, they bypass the requirement for Ste20 but not the requirement for pheromone. The concordant behavior of all activated mutants suggests that amplification is functionally separable from regulation of Ste11 activity by phosphorylation and conformational changes. By means of FACS analysis of cells containing a P FUS1 -GFP reporter (Figure 1F) , we saw no evidence that constitutively active Ste11 could induce maximum signaling in a minority of cells, as might accompany switch-like signaling [15, 16] . Instead, STE11-Asp3 caused a relatively uniform and mild increase in basal signaling, yet conferred robust pheromone response to ste20D cells. Clearly then, pheromone modulates signaling efficiency in a way that is separable from the Ste20 / Ste11 phosphorylation step.
Though independent of Ste20, pheromone amplification of Ste11 signaling required the scaffold protein, Ste5 ( Figure 1E , right), as well as the a-factor receptor (Ste2) and the Gb (Ste4) subunit (see Figure S1 in the Supplemental Data available with this article online). Because pheromone triggers recruitment of Ste5 to the plasma membrane [4] [5] [6] [7] , we hypothesized that this translocation might enhance signaling from activated Ste11 through the kinase cascade, in addition to promoting the initial Ste20 / Ste11 step. Targeting Ste5 to the plasma membrane via a C-terminal transmembrane domain (CTM) causes constitutive, Ste20-dependent signaling [4] . Here, by bypassing Ste20 with the Ste11-4/Asp3 mutant, we found that fusing Ste5 to the CTM motif also amplified Ste11 signaling (Figure 2A) . Interestingly, Ste20-independent amplification was freed from a localization constraint that normally applies to Ste20-dependent signaling. This was revealed by fusing *Correspondence: peter.pryciak@umassmed.edu Ste5 to transmembrane domains that localize to internal membranes such as endoplasmic reticulum (ER) and Golgi, rather than the plasma membrane ( Figure S2 ). As found previously [4] , Ste20-dependent signaling required Ste5 to localize to the plasma membrane (Figure 2A, black bars) , where Ste20 itself localizes [9, 10] . But when Ste20 was bypassed with the Ste11-4/Asp3 mutant, membrane localization of Ste5 amplified signaling regardless of the target membrane (Figure 2A , gray bars).
Relatedly, we also found that Gbg could trigger amplification of Ste11 signaling from internal membranes ( Figure 2B ). Transmembrane anchors were attached to a derivative of the Gg subunit, Ste18, that lacks its native C-terminal membrane-tethering sequence (Ste18DC; [4] ); these were then cooverexpressed with the Gb subunit (P GAL1 -STE4), to activate Gbg without pheromone. Ste20-dependent signaling (Ste11-WT) required the domain that targets the plasma membrane (CTM), whereas amplification of Ste11 signaling (Ste11-4/Asp3) was [1, 2, 23] . Activation of the mating and HOG pathways is associated with membrane recruitment of a scaffold protein (Ste5 or Pbs2) [4, 8] . For simplicity, the activator of Cdc42 (the GEF Cdc24) is not shown. (B) Alternate views of signaling circuitry. Left: Stimuli act at the beginning of each pathway, increasing signaling through each required step. Right: Stimuli act in the middle of the pathway, boosting signal transmission from upper to lower steps. The view on the right, in which regulation occurs after a branchpoint from common components, provides an inherent mechanism for signaling specificity. Previous studies argue that pheromone stimulates the Ste20 / Ste11 step rather than earlier steps [3, 4, 9] . Results here argue that the signaling output from activated Ste11 is amplified in a pathway-specific manner. (C) Constitutive activation of Cdc42, Ste20, and Ste11 yields only minimal signaling that is substantially amplified by pheromone. Wild-type cells harbored vector, P GAL1 -CDC42 L61 , or P GAL1 -STE20DN, and ste11D cells harbored STE11-4 expressed from its native promoter. For immunoblots (top), cells also contained a Fus3-myc construct and were treated with 2% galactose for 90 min, with 5 mM a-factor added during the final 15 min. For transcriptional induction of the FUS1-lacZ reporter construct (bottom), cells were treated with 2% galactose 6 5 mM a-factor for 3 hr; n = 3. (D) Activation mechanism of wild-type Ste11 (wt) by Ste20 phosphorylation, involving conversion from an autoinhibited (inactive) conformation to an open (active) conformation. Mutant forms of Ste11 mimic either inactive (Ala3) or active (Asp3, 11-4) states [3, 11] . (E) Activated forms of Ste11 bypass the requirement for Ste20 but not the requirement for pheromone. Ste11 derivatives were expressed from the native STE11 promoter in the indicated strains, and FUS1-lacZ expression was measured 6 a-factor (5 mM for 2 hr; n = 4). (F) FACS analysis of cells containing an integrated P FUS1 -GFP reporter. The vertical dashed line shows mean basal fluorescence in STE11-WT cells. STE11-Asp3 does not cause maximal signaling in a minority of cells, but allows ste20D cells to respond to a-factor (aF; 10 mM for 2 hr). Data in bar graphs show the mean 6 SD.
achieved by targeting Gbg to internal membranes via the Sec22 and Sed5 domains ( Figure 2B ). Untargeted Ste18DC did not amplify Ste11 signaling, suggesting that binding of cytoplasmic Gbg to Ste5 is not sufficient and hence that membrane recruitment is required, consistent with the results of direct Ste5 targeting. Together, our findings indicate that Ste5 membrane recruitment by Gbg ordinarily serves two roles: the first is to promote the Ste20 / Ste11 activation step, and the second is to amplify signaling from active Ste11 through the remainder of the kinase cascade. Presumably, both are normally triggered at the plasma membrane, but when the first step is bypassed via preactivated Ste11 mutants, the second step can be promoted by recruiting Ste5 to any membrane.
The role of membrane localization in Ste11 amplification could be an effect of membrane lipids on protein activity, or it could reflect the ability of membrane recruitment to concentrate signaling proteins [17] . To test the latter possibility, we compared membrane localization with forced oligomerization of Ste5. We found that fusion of Ste5 to a homodimerizing GST moiety [18] [19] [20] could amplify Ste11 signaling ( Figure 2C ), though somewhat less potently than Ste5-CTM. Similar results were reported recently [14] . Control experiments show that these effects are not simply due to distortion of the Ste5 C terminus ( Figure S3A ). Signaling initiated by Cdc42 and Ste20 was also amplified by membrane targeting ( Figure 2D ) or dimerization ( Figure 2E ) of Ste5, revealing that they have cryptic signaling activity that requires amplification to produce significant output. Importantly, we determined that Ste5-GST amplified Ste11 signaling in the absence of both Gb (Ste4; Figure 2C ) and a membrane binding domain in the Ste5 N terminus ( Figure S3B) , and thus was independent of the known ability of dimerization to promote Ste5 membrane localization [7, 20] . Conversely, the effect of membrane targeting did not require oligomerization via the RING-H2 domain [18, [20] [21] [22] , because this region was absent in the membrane-targeted Ste5DN derivatives (Figure 2A) . Therefore, dimerization and membrane targeting might act in distinct ways, or in each case the Ste11 signaling. P GAL1 -GFP-STE5 plasmids were tested for Ste20-dependent signaling (black bars) or Ste20-independent signaling (gray bars); n = 6. Localization of each transmembrane domain fusion to the plasma membrane (PM) versus internal membranes (ER/Golgi) is summarized (see Figure S2) . These experiments used Ste5DN (= D1-214) to avoid competing plasma membrane-targeting information in the Ste5 N terminus [7] . Inset: anti-GFP immunoblot of GFP-Ste5 derivatives, in the same left-to-right order as the bar graph. pertinent effect may be to promote the colocalization of multiple scaffold molecules.
Hyperactive Ste5 mutants have been isolated that bypass Ste4 (Gb), and the resulting signaling requires Ste20 ( [19] and Figure 3A) . We found that these Ste5 mutants (minus the GST tag) also amplified Ste11 signaling ( Figure 3B) . Nevertheless, the mutants differentially enhanced the two signaling steps: the N-terminal mutant P44L was strongest when signaling required Ste20 ( Figure 3A , black bars [ste4D ste5D]; see also [7, 19] ), whereas the C-terminal mutant S770N was strongest at Ste11 amplification ( Figure 3B ). The Ste5 N terminus contains a membrane binding domain ( Figure 3F ), and certain hydrophobic substitutions enhance its membrane affinity, triggering membrane localization and Ste20-dependent signaling [7] . Accordingly, these same hydrophobic substitutions (P44L, P44F, T52L, T52F; [7] ) triggered Ste11 amplification ( Figure 3C ), whereas others (P44N, T52N, T52H) did not. These results explain the amplification effect of the N-terminal Ste5 mutants and provide further evidence that membrane localization amplifies Ste11 signaling.
Unlike the N-terminal mutants, however, the Ste5 C-terminal mutant S770N has no evident effect on localization [7, 19] and yet is especially potent at Ste11 amplification ( Figure 3B ). Further suggesting a distinct mechanism, the amplifying effect of S770N remained intact when combined with large deletions (D26-138 and D1-214; Figure 4D ) that remove several N-terminal binding domains (e.g., membrane, Gbg, oligomerization). Thus, rather than inducing signaling-promoting contacts between N-and C-terminal domains, as proposed previously [19] , we suggest that S770N may have a relatively ''local'' effect within Ste5, such as altering Ste7 binding (see Figure S4) . In striking contrast, however, when signaling still required Ste20, the hyperactivity of Ste5-S770N was entirely dependent on the Ste5 N terminus ( Figure 3E ). The simplest explanation for this difference is that when Ste11 is wild-type, membrane binding by the Ste5 N terminus is required to promote an initial low level of Ste20 / Ste11 activation at the plasma membrane, which is then amplified by Ste5-S770N.
The experiments above show that mating pathway signaling is buffered against excess activity from Cdc42, Ste20, and Ste11. We compared this behavior with the HOG pathway, which shares these same proteins ( Figure 1A ; [23] ). First, the osmotic resistance defect of cells lacking Ste20 could be bypassed by expressing Ste11-Asp3 from its native promoter (Figure 4A) . Second, Hog1 phosphorylation in cells expressing native Ste11-Asp3 was submaximal, and yet was strongly amplified by the hyperosmotic stimulus (Figure 4B ). This agrees with the fact that Sho1 is required for osmotic resistance in cells expressing activated Ste11 [24] . Remarkably, although both mating and osmotic stimuli could amplify signaling from preactivated (A) Ste20-dependent signaling by hyperactive Ste5 mutants. Strong signaling by these Ste5 derivatives requires fusion to GST [7, 19] . The wild-type (wt) Ste5-GST fusion triggers signaling in STE4 + cells, whereas only the mutants signal in ste5D ste4D cells, and this depends on Ste20 (n = 3). (B) Hyperactive Ste5 mutants can amplify Ste11 signaling. Cells harbored a STE11 plasmid and a P GAL1 -GFP-STE5 plasmid; n = 4. Because these mutants were initially isolated in a STE5-GST context [19] , which itself amplifies Ste11 signaling, they were transferred to a context lacking the GST tag for these experiments. (C) Amplification by the N-terminal Ste5 mutants correlates with enhanced membrane binding. Cells harbored a STE11 plasmid and a P GAL1 -GFP-STE5 plasmid; n = 3. Substitution of Pro44 and Thr52 with hydrophobic residues (Leu, Phe) triggers membrane localization of Ste5 [7] . The stronger amplifying effects of Thr52 mutations agree with their stronger membrane association [7] . (D) The ability of Ste5-S770N to amplify Ste11 signaling is independent of N-terminal Ste5 domains involved in membrane binding, Gbg binding, and oligomerization (see [F] ). Cells harbored a STE11 plasmid and a P GAL1 -GFP-STE5 plasmid; n = 4. (E) The ability of Ste5-S770N to trigger Ste20-dependent signaling requires the Ste5 N terminus. Cells harbored P GAL1 -STE5-GST plasmids; n = 6. Ste11, pathway specificity was still maintained, and only the proper MAPK (Fus3 or Hog1) was activated (Figure 4C ). Results were similar in ste20D cells, showing that the ability of each stimulus to activate a unique MAPK is separable from regulation of the Ste20 / Ste11 step. Therefore, in addition to sharing protein components, the mating and HOG pathways share a similar behavior. In each pathway, activation of the downstream-most shared component, Ste11, is not sufficient for robust signaling. Instead, signaling downstream of activated Ste11 is separately boosted by pathway stimuli, yet specifically directed toward the appropriate MAPK.
Given that both mating and HOG pathway stimuli amplify Ste11 signaling, it is noteworthy that the scaffolds for each pathway, Ste5 and Pbs2, are recruited to the plasma membrane [4, 8] . In each case, this was thought to promote the Ste20 / Ste11 step, yet our findings suggest that membrane localization can play an additional role after Ste11 is activated. Similarly, in the mammalian Raf-MEK-ERK cascade, membrane localization can convert low Raf activity into high signaling output [16] . Yet in no case is the precise molecular mechanism known. Membrane lipids could trigger a conformational change in either the scaffold or one of the kinases. Alternatively, membrane recruitment could amplify signaling via a concentration effect, promoting interactions among kinases by colocalizing them in a reduced volume [17, 25] . This model warrants serious consideration, as it could be broadly applicable and would explain the similar amplification effects of membrane targeting and forced dimerization of Ste5. Indeed, membrane recruitment can raise local concentrations by 100-to 1000-fold [17, 26] , which can increase the number of complexes between two proteins when even a moderate fraction of each (e.g., 10%) is colocalized [17] . The benefits of colocalization are less obvious for scaffolded pathways, since the kinases are assumed already to be in close mutual proximity, yet signaling would be enhanced under several scenarios: (1) if signaling involves homodimeric interactions of any of the included components (e.g., Ste5-Ste5, Ste11-Ste11, Ste7-Ste7, or Fus3-Fus3); (2) if only a minority of scaffold proteins in the cytoplasm have all kinase binding sites occupied simultaneously; or (3) if steric hinderance precludes functional interaction between two kinases bound to the same scaffold molecule, so that ''productive'' interactions occur preferentially in trans. While the efficiency relative to activation in cis is unknown, prior studies suggest that kinase activation on Ste5 can occur in trans [18, 21] . This was taken to suggest a functional role for Ste5 dimerization, but could be explained equally well by the concentrating effect of Ste5 membrane recruitment, and without the need for specific Ste5-Ste5 contacts. This view can help reconcile why the Gbg binding site in Ste5 is required for trans activation [18, 21] and yet is dispensible when the role of Gbg in recruitment is bypassed [4, 7, 22] , and why Ste5 oligomerization is not obviously regulated [21, 22] , unlike membrane recruitment [4] [5] [6] [7] .
In conclusion, our findings illustrate how membrane recruitment of a MAP kinase cascade scaffold protein triggers both the initiation and amplification of signaling through the kinase cascade. This relates to examples in mammalian cells involving membrane translocation of kinases and scaffolds [16, 27] , and where membrane clustering enhances signaling by preactivated receptor tyrosine kinases [28] . In addition, our observations reveal harmony between the underlying logic of signaling circuitry in two pathways that use common components (mating and HOG). In each case, signaling is optimal only when steps in the middle of the pathway circuit are stimulated, thus minimizing crosspathway signaling (B) HOG pathway signaling by Ste11-Asp3 is amplified by hyperosmotic stimulation. Cells harboring different STE11 alleles expressed from their native promoter plus a Hog1-GFP construct were treated 6 0.5 M NaCl for 5 min. Hog1 phosphorylation was detected via antiphospho-p38 antibodies, and Hog1 levels were detected via anti-GFP antibodies. (C) Mating and HOG pathway stimuli trigger signaling in a pathwayspecific manner even when the Ste20 / Ste11 step is bypassed. Strains expressed Ste11-Asp3 plus either Fus3-myc or Hog1-GFP. Cells were treated with no stimulus, 10 mM a-factor (15 min), or 0.5 M NaCl (5 min). Levels of Fus3 and Hog1 were detected via anti-myc and anti-GFP antibodies, respectively. Phosphorylation was detected via anti-phospho-p44/42 and anti-phospho-p38 antibodies.
that might otherwise result from sharing components in earlier steps. This view is an extension of one proposed recently based on complementary results [14] , which our work expands by separating amplification from the Ste20 / Ste11 step, by linking amplification to a stimulus-regulated event (i.e., Ste5 membrane recruitment), and by uncovering strikingly parallel regulatory behavior between mating and HOG pathways. Similar strategies may be employed by other signaling pathways (e.g., [29] ), and a better understanding of which steps are rate limiting in vivo may assist computational modeling of signal transduction [30] .
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